Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review.

Khanyisani ZiqubuPhiwayinkosi V DludlaSinenhlanhla X H MthembuBongani NkambuleSithandiwe E Mazibuko-Mbeje

Published in: Adipocyte (2024)

Current clinical evidence emphasizes that the circulating levels of Nrg4 are decreased in morbid obesity, and it also highlights that Nrg4 May serve as a potential prognostic biomarker for obesity-related metabolic diseases.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
skeletal muscle
body mass index
physical activity
risk assessment